• Schindler TH, Anderson A, El Ghannudi S, Imperiale A. Identification and characterization of cardiac sarcoidosis with positron emission tomography. Eur J Clin Invest. 2022;52:e13722. Concise editorial of PET for the detection and characterization of cardiac sarcoidosis.

Article  CAS  PubMed  Google Scholar 

• Schindler TH, Solnes L. Role of PET/CT for the Identification of Cardiac Sarcoid Disease. Ann Nucl Cardiol. 2015;1:79–86. Comprehensive review of PET for the detection and characterization of cardiac sarcoidosis.

Article  Google Scholar 

•• Kruse MJ, Kovell L, Kasper EK, Pomper MJ, Moller DR, Solnes L, et al. Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2017;10:157–67. First study that demonstrates the potential added diagnostic value of PET-determined myocardial blood flow and treatment monitoring in cardiac sarcoidosis.

Article  PubMed  Google Scholar 

•• Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC Expert Consensus Document on the Role of (18)F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017;58:1341–53. Comprehensive position paper on the pathophysiology, clinical manifestation, outcome, and cardiovascular PET application in sarcoidosis.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA. 2011;305:391–9.

Article  CAS  PubMed  Google Scholar 

• Trivieri MG, Robson PM, Vergani V, Vergani V, LaRocca G, Romero-Daza AM, et al. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2024;17(4):425–7. https://doi.org/10.1016/j.jcmg.2023.11.010. Online ahead of print. First study that demonstrates the important role of integrated PET/MR in outcome predition in cardiac sarcoidosis.

Article  Google Scholar 

• Sperry BW, Tamarappoo BK, Oldan JD, Javed O, Culver DA, Brunken R, et al. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on (18)F-FDG PET Scans for Suspected Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2018;11:336–45. Important study that demonstrates PET determined cardiac parameters as high risk predictors for cardiovascular outcome in sarcoidosis.

Article  PubMed  Google Scholar 

Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53:241–8.

Article  CAS  PubMed  Google Scholar 

Schatka I, Bengel FM. Advanced imaging of cardiac sarcoidosis. J Nucl Med. 2014;55:99–106.

Article  PubMed  Google Scholar 

Larson SR, Pieper JA, Hulten EA, Ficaro EP, Corbett JR, Murthy VL, et al. Characterization of a highly effective preparation for suppression of myocardial glucose utilization. J Nucl Cardiol. 2020;27:849–61.

Article  PubMed  Google Scholar 

Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, et al. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2016;43:259–69.

Article  CAS  PubMed  Google Scholar 

•• Birnie D, Ha AC, Gula LJ, Chakrabarti S, Beanlands RS, Nery P. Cardiac Sarcoidosis. Clin Chest Med. 2015;36:657–68. Comprehensive review on the pathophysiology, clinical manifestation, diagnosis, outcome, and treatment of cardiac sarcoidosis.

Article  PubMed  Google Scholar 

• Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63:329–36. First study that demonstrates the important role of FDG-PET in outcome predition in cardiac sarcoidosis.

Article  PubMed  Google Scholar 

Divakaran S, Stewart GC, Lakdawala NK, Padera RF, Zhou W, Desai AS, et al. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019;12:e008975.

Article  PubMed  PubMed Central  Google Scholar 

Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166–74.

Article  PubMed  Google Scholar 

Schindler TH, Dilsizian V. Coronary microvascular dysfunction: clinical considerations and noninvasive diagnosis. JACC Cardiovasc Imaging. 2020;13:140–55.

Article  PubMed  Google Scholar 

Schindler TH, Fearon WF, Pelletier-Galarneau M, Ambrosio G, Sechtem U, Ruddy TD, et al. Myocardial perfusion PET for the detection and reporting of coronary microvascular dysfunction. A JACC: Cardiovascular Imaging Expert Panel Statment. JACC Cardiovasc Imaging. 2023;16(4):536–48.

Article  PubMed  Google Scholar 

Verma A, Ramayya T, Upadhyaya A, Valenta I, Lyons M, Marschall J, et al. Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve. Eur J Clin Invest. 2022;52:e13871.

Article  CAS  PubMed  Google Scholar 

Lim SL, Lam CS, Segers VF, Brutsaert DL, De Keulenaer GW. Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction. Eur Heart J. 2015;36:2050–60.

Article  CAS  PubMed  Google Scholar 

Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018;39:840–9.

Article  CAS  PubMed  Google Scholar 

Selvaraj S, Seidelmann SB, Soni M, Soni M, Bhattaru A, Margulies KB, et al. Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PET. Eur Heart J Cardiovasc Imaging. 2022;23:1690–7.

Article  PubMed  PubMed Central  Google Scholar 

Selvaraj S, Margulies KB, Dugyala S, Schubert E, Tierney A, Pryma DA, et al. Comparison of exogenous ketone administration versus dietary carbohydrate restriction on myocardial glucose suppression: a crossover clinical trial. J Nucl Med. 2022;63:770–6.

CAS  PubMed  PubMed Central  Google Scholar 

Rojulpote C, Bhattaru A, Jean C, Adams SL, Patel V, Vidula MK, et al. Effect of immunosuppressive therapy and biopsy status in monitoring therapy response in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2022;15:1944–55.

Article  PubMed  Google Scholar